MAGDELENA FORD: Open Payments
NPI 1538721386 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 10 payments from 5 companies in 2025. Trend: 2023 $231 · 2024 $746 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $261 |
| AstraZeneca Pharmaceuticals LP | 4 | $203 |
| Exelixis Inc. | 1 | $109 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Gilead Sciences, Inc. | 1 | $23 |
Products named: OPDIVO, ENHERTU, CABOMETYX, Trodelvy.
Industry payments across CA — which companies pay providers there.
